Report: Fast Revenue Growth For Neurostimulation Devices
NEW YORK, Jan. 5, 2015 /PRNewswire/ -- The global market for neurostimulation is valued at $4.7 billion for 2014, representing device sales for both external and implantable stimulation devices. Combined growths for the segments were 8.3% over the 2009 market value of $3.2 billion. The finding was made in Kalorama Information's recently released report, The World Market for Neurostimulation Devices.
The report can be found at: http://www.kaloramainformation.com/Neurostimulation-Devices-TENS-8520946/.
"It is one of many device categories growing a bit faster than the device market as a whole," said Bruce Carlson, Publisher of Kalorama Information.
Neurostimulation is often associated with use in pain relief or therapy, according to the report. It is naturally segmented into two classifications: those that use external electrodes and those that use internal (implanted) electrodes. The two common external electrode methods are electromuscular stimulation (EMS) and transcutaneous electrical nerve stimulation (TENS), which both use similar equipment and external electrodes. Spinal cord stimulation and vagus nerve stimulation rely on implanted electrodes to mitigate pain or minimize seizures or tremors.
During the forecast period several individual segments will likely remain strong fueling the market to reach $7 billion by 2019. External devices will likely show some increases as newer technologies such as rTMS continue to gain positive results. Implantable segments will remain strong with deep brain stimulation, sacral nerve stimulation, and spinal cord stimulation segments contributing to strong markets while newer technologies will continue to expand the market potential. Technologies such as carotid sinus nerve stimulators and phrenic nerve stimulators will experience progressive adoption contributing to the market's growing opportunity and security.
Key players in the market are also discussed including Medtronic, St Jude Medical, Cochlear Ltd., Boston Scientific, Cyberonics and Advanced Bionics (Sonova).
Kalorama's report The World Market for Neurostimulation Devices (TENS, Carotid Sinus Nerve, Cochlear Implant, Deep Brain, Gastric Electrical, Phrenic Nerve, Sacral Nerve, Spinal Cord, Vagus Nerve, TMS, TNS and Other Stimulation Devices) provides important business planning information for marketers, including leading market players by market segment, competitive environment, key products and emerging indications by technology. Information about the report is available at: http://www.kaloramainformation.com/Neurostimulation-Devices-TENS-8520946/.
About Kalorama Information -- Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.
Contact:
Bruce Carlson
(212) 807-2622
[email protected]
www.KaloramaInformation.com
Logo - http://photos.prnewswire.com/prnh/20140801/132634
SOURCE Kalorama Information
Share this article